v3.25.1
Segment information
 3 Months Ended
Mar. 30, 2025
Segment Reporting [Abstract]  
Segment information Segment information
An operating segment is a component (a) that engages in business activities from which it may earn revenues and incur expenses, (b) whose operating results are regularly reviewed by the chief operating decision maker (in our case, our President and Chief Executive Officer) to make decisions about resources to be allocated to the segment and to assess its performance, and (c) for which discrete financial information is available. The chief operating decision maker utilizes segment operating profit to evaluate operating expenses through a comparison of budget to actual results as well as an analysis of operating expenses as a percentage of revenue. We do not evaluate our operating segments using discrete asset information.
We have three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Our reportable segments primarily design, manufacture and distribute medical devices primarily used in critical care and surgical applications and generally serve two end-markets: hospitals and healthcare providers, and home health. The products of these segments are most widely used in the acute care setting for a range of diagnostic and therapeutic procedures and in general and specialty surgical applications. The Americas also includes our OEM product portfolio that designs, manufactures and supplies devices and instruments for other medical device manufacturers.
The following tables present our segment results for the three months ended March 30, 2025 and March 31, 2024:
 Three Months Ended March 30, 2025
 AmericasEMEAAsiaSegment Total
Net revenues$475,724 $151,159 $73,786 $700,669 
Cost of goods sold
190,431 69,653 27,693 287,777 
Research and development expenses20,939 8,555 4,366 33,860 
Selling, general and administrative expenses106,569 39,678 22,785 169,032 
Segment operating profit (1)
$157,785 $33,273 $18,942 $210,000 
 Three Months Ended March 31, 2024
 AmericasEMEAAsiaSegment Total
Net revenues$493,983 $159,656 $84,210 $737,849 
Cost of goods sold
200,738 74,614 30,115 305,467 
Research and development expenses20,978 11,009 4,461 36,448 
Selling, general and administrative expenses111,583 38,382 23,549 173,514 
Segment operating profit (1)
$160,684 $35,651 $26,085 $222,420 
(1)Segment operating profit represents income from continuing operations before interest, loss on extinguishment of debt and taxes adjusted to exclude unallocated corporate expenses manufacturing variances other than fixed manufacturing cost absorption variances, restructuring and impairment charges. See reconciliation of segment operating profit measures for further details.

Three Months Ended
March 30, 2025March 31, 2024
Reconciliation of segment operating profit measure
Segment operating profit$210,000 $222,420 
Other unallocated expenses (1)
79,675 86,415 
Restructuring charges, separation costs and impairment charges
4,755 2,659 
Pension settlement charge— 138,139 
Income (loss) from continuing operations before interest and taxes
$125,570 $(4,793)
(1) Other unallocated expenses include expenses within costs of goods sold, research and development and selling, general and administrative costs and primarily consist of manufacturing variances other than fixed manufacturing cost absorption variances and unallocated corporate function expenses.
 Three Months Ended
Depreciation and amortization
March 30, 2025March 31, 2024
Americas$46,661 $47,155 
EMEA12,177 11,520 
Asia3,808 2,682 
Corporate (1)
4,685 4,687 
Consolidated depreciation and amortization$67,331 $66,044 
(1)Reflects depreciation and amortization included within other allocated expenses per reconciliation of segment operating profit measure.